Stockreport

Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine

Guardant Health, Inc.  (GH) 
Last guardant health, inc. earnings: 2/24 04:03 pm Check Earnings Report
PDF Study shows blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90%Results pave the way for first potential FDA-approved b [Read more]